News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

14,252 Results

Type

Article (2911)
Company Profile (2)
Press Release (11339)

Section

Business (5053)
Career Advice (41)
Deals (778)
Drug Delivery (15)
Drug Development (3079)
Employer Resources (9)
FDA (466)
Job Trends (769)
News (8930)
Policy (1195)

Tag

Date

Today (6)
Last 7 days (12)
Last 30 days (83)
Last 365 days (919)
2024 (861)
2023 (857)
2022 (1719)
2021 (1703)
2020 (1505)
2019 (888)
2018 (622)
2017 (757)
2016 (797)
2015 (925)
2014 (632)
2013 (428)
2012 (421)
2011 (362)
2010 (326)

Location

Africa (52)
Asia (1182)
Australia (156)
California (54)
Canada (18)
China (13)
Connecticut (7)
Delaware (20)
Europe (3657)
Florida (13)
Illinois (7)
Japan (6)
Maryland (9)
Massachusetts (51)
New Jersey (30)
New York (12)
North Carolina (10)
Northern California (33)
Ohio (15)
South America (54)
Southern California (14)
Washington D.C. (5)

Filters

Type

Article (2911)
Company Profile (2)
Press Release (11339)

Section

Business (5053)
Career Advice (41)
Deals (778)
Drug Delivery (15)
Drug Development (3079)
Employer Resources (9)
FDA (466)
Job Trends (769)
News (8930)
Policy (1195)

Tag

Date

Today (6)
Last 7 days (12)
Last 30 days (83)
Last 365 days (919)
2024 (861)
2023 (857)
2022 (1719)
2021 (1703)
2020 (1505)
2019 (888)
2018 (622)
2017 (757)
2016 (797)
2015 (925)
2014 (632)
2013 (428)
2012 (421)
2011 (362)
2010 (326)

Location

Africa (52)
Asia (1182)
Australia (156)
California (54)
Canada (18)
China (13)
Connecticut (7)
Delaware (20)
Europe (3657)
Florida (13)
Illinois (7)
Japan (6)
Maryland (9)
Massachusetts (51)
New Jersey (30)
New York (12)
North Carolina (10)
Northern California (33)
Ohio (15)
South America (54)
Southern California (14)
Washington D.C. (5)

14,252 Results for "astrazeneca".

Sort By

Prostate cancer

AstraZeneca’s Truqap Redeems Itself with Phase III Prostate Cancer Win

Truqap’s positive clinical data comes after it failed a late-stage study in metastatic triple-negative breast cancer. It helps AstraZeneca position itself as a top player in the prostate cancer space, alongside its Big Pharma colleagues.

November 26, 2024
·
2 min read
·
Tristan Manalac
China

AstraZeneca’s China Head Taken Into Custody by Chinese Authorities: Reports

While it remains unclear why AstraZeneca China President Leon Wang has been detained, news of his arrest comes just days after it was reported that he was under investigation for alleged medical insurance fraud in the country.

November 8, 2024
·
2 min read
·
Tristan Manalac
China

AstraZeneca’s Stock Price Takes a Hit as China Chief Investigated for Insurance Fraud

BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” to AstraZeneca, but contends that the share selloff is “overdone” and likely a knee-jerk reaction by investors.

November 6, 2024
·
2 min read
·
Tristan Manalac
Podcast

AbbVie’s Surprise Schizophrenia Flop, AstraZeneca’s China Drama, Hope in Huntington’s, More

A tale of two multi-billion schizophrenia deals, AstraZeneca touts strong sales while deflecting questions about an investigation into China exec, the Huntington’s pipeline builds momentum and layoffs continue with Sana Biotechnology and 23andMe.

November 13, 2024
·
1 min read
·
Heather McKenzie
Cancer

AstraZeneca/Daiichi Sankyo, BioNTech, Merus to Present Promising Cancer Therapies at ESMO Asia 2024

At the conference, AstraZeneca and Daiichi Sankyo will present their case for Dato-DXd in NSCLC, while BioNTech and Merus will reveal promising mid-stage data for their respective cancer candidates.

December 2, 2024
·
4 min read
·
Tristan Manalac
Obesity

AstraZeneca Bolsters Obesity Pipeline With Promising Early Data for Candidates

While expected and seen as largely incremental, Jefferies analyst Peter Welford in a Tuesday note to investors said the detailed data for three early-stage assets support moving them into Phase IIb studies and creates a “foothold” for AstraZeneca in the weight loss space.

November 5, 2024
·
3 min read
·
Tristan Manalac
People

From Argentina to America: A Physician’s Journey to Pharma and AstraZeneca

Carlos Doti has moved countries and changed jobs, but one thing hasn’t changed. Making an impact on patient care has always been a priority for the AstraZeneca executive.

October 10, 2024
·
6 min read
·
Angela Gabriel
Cardiovascular disease

AstraZeneca Puts $2B On The Line for Preclinical Heart Disease Drug

For an exclusive license to the preclinical Lp(a) disruptor, AstraZeneca is paying CSPC Pharmaceutical Group $100 million upfront and offering up to $1.92 billion in regulatory and commercial milestones.

October 7, 2024
·
2 min read
·
Tristan Manalac
Approvals

AstraZeneca’s Imfinzi-Lynparza Combo Wins Landmark EU Nod for Endometrial Cancer

The European Union has approved the first-ever combination therapy consisting of an immunotherapy and a PARP inhibitor for the treatment of endometrial cancer, AstraZeneca announced Wednesday.

August 14, 2024
·
2 min read
·
Tristan Manalac
Cancer

AstraZeneca’s Calquence Aces Phase III CLL Trial, Eyes Fixed-Duration Approval

AstraZeneca is seeking a fixed-duration approval for Calquence, which will allow patients with chronic lymphocytic leukemia to take breaks from the therapy and prevent excessive toxicities and drug resistance.

July 30, 2024
·
2 min read
·
Tristan Manalac

1 of 1,426

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin